Ovid Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.

About OVID

Ovid Therapeutics, Inc. is a biopharmaceutical company, engaged in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

CEO

Jeremy Max Levin

CEOJeremy Max Levin

Employees

Employees57

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2014

Founded2014

Employees

Employees57

OVID Key Statistics

Market cap

130.98M

Market cap130.98M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

66.32K

Average volume66.32K

High today

$1.91

High today$1.91

Low today

$1.80

Low today$1.80

Open price

$1.85

Open price$1.85

Volume

26.17K

Volume26.17K

52 Week high

$3.78

52 Week high$3.78

52 Week low

$1.65

52 Week low$1.65

OVID Earnings

-$0.38

$0.59

$1.56

$2.53

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, Pre-Market

ActualExpected Nov 9, Pre-Market

Ovid Therapeutics

Why Robinhood?

Ovid Therapeutics, Inc. is a biopharmaceutical company, engaged in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY. Show more

OVID Key Statistics

Ovid Therapeutics, Inc. is a biopharmaceutical company, engaged in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.